Home SocietyGrant Uncertainty Puts HIV and TB Care at Risk in Congo

Grant Uncertainty Puts HIV and TB Care at Risk in Congo

by Michael Mabiala

Funding alarm from National Coordination Committee

In a measured yet pressing tone, the National Coordination Committee, the body overseeing Global Fund grants in Congo, warned this week that life-saving supplies of antiretrovirals and anti-tuberculosis drugs could run dry in 2026 unless fresh resources are secured.

Nearly 20,000 people living with HIV and about 4,000 tuberculosis patients would be directly exposed, according to figures released during the Fund’s end-of-mission briefing in Brazzaville, an event that gathered health officials, civil-society leaders and international partners around the same table.

Rising HIV burden among youth

Eplakessi Kouadjani, principal portfolio manager for Congo, Togo and Benin, underlined that the Republic of Congo continues to face “stubborn epidemics”, with HIV prevalence rising most sharply among adolescents and young adults who often discover their status late.

While the national treatment coverage for HIV has improved in recent years, Kouadjani cautioned that adherence gains could “evaporate overnight” if stocks fail, jeopardising progress toward the 95-95-95 goals endorsed by regional heads of state.

Tuberculosis deaths reveal wider challenge

Tuberculosis shows a similar paradox. The country reports a commendable 100 percent therapeutic coverage, yet health records still attribute 83,000 deaths to the disease, a gap that experts say reflects late detection, co-infections and lingering stigma that keeps patients away from formal care.

Public-health physician Dr. Arlette Okemba, interviewed after the session, explained that “coverage on paper is not coverage in the neighbourhood clinic”, adding that medical teams sometimes ration drugs to stretch dwindling inventories through the final quarter of each budget cycle.

Global Fund grant and domestic effort

The Republic of Congo presently benefits from a 90-million-euro allocation from the Global Fund for the 2024-2026 cycle, a package negotiated to sustain HIV, tuberculosis and malaria programmes, purchase diagnostics and upgrade cold-chain logistics across health districts.

CCN president Esmo Valérie Maba Moukassa praised the grant for delivering “satisfying levels on several health indicators linked to the three pandemics”, noting improvements in viral-load monitoring and community outreach led by youth associations in Brazzaville and Pointe-Noire.

Yet she tempered optimism with a clear warning: “If our pleas are not heard and subsidies are reduced, we will have to consider mobilisation actions to make our concerns known.” Her statement signalled a readiness for measured advocacy rather than confrontation.

Shared responsibility under discussion

Participants at the briefing converged on the need to diversify financing, calling on the private sector, bilateral partners and even sovereign creditors to top up medicine lines should external grants tighten in a shifting global aid landscape.

Several mining and telecom companies present signalled an appetite for public-private health partnerships, arguing that a healthier workforce reduces absenteeism and boosts productivity, although no firm pledges were announced on the record.

Government commitment reiterated

Senior officials from the Ministry of Health reiterated the government’s commitment to uninterrupted treatment, emphasising that securing medicines aligns with President Denis Sassou Nguesso’s broader vision of human-capital development stated in the National Development Plan.

A technical task force has been asked to map domestic budget lines, potential concessional loans and in-kind donations so that orders for 2025 and 2026 can be placed well before current stocks reach critical thresholds.

Health economist Jean-Pierre Bouity, who has advised previous procurement drives, argued that early purchasing could unlock bulk discounts and mitigate shipping delays that were experienced during the pandemic period.

Strengthening data and supply chains

Digital inventory tools piloted in four departments flag real-time consumption, but national roll-out remains incomplete because of bandwidth gaps and staff training needs, leaving central planners reliant on monthly paper reports that arrive late from remote health zones.

Logisticians at the national medical store said newer warehouse management software, donated under the same Global Fund grant, will not deliver its full value unless backed by reliable electricity and dedicated maintenance budgets that guarantee bar-code scanners and servers remain operational.

Dr. Okemba observed that supply-chain modernisation is as much about people as technology, urging that pharmacists, nurses and drivers receive continuous mentoring so that forecasting, ordering and last-mile delivery form a seamless loop.

Regional health directors in Niari and Likouala expressed confidence that such capacity building will shorten lead times once fully funded.

Maternal and child health angle

Kouadjani stressed that safeguarding mothers and children remains pivotal, since paediatric formulations and prevention-of-mother-to-child interventions suffer first whenever central warehouses confront shortages, thereby risking new infections and complicating efforts to meet the Sustainable Development Goals.

Quiet urgency toward the 2026 horizon

For now, clinics continue to dispense medication, yet pharmacists already monitor expiry dates with unease, knowing procurement cycles can span fourteen months from tender to delivery.

In the words of community health worker Marie-Ange Ngoma, “We are trained to reassure patients, but we also need reassurance. A missed pill is more than a statistic; it is a setback in someone’s life.”

The coming months will therefore test whether multisector dialogue can translate into concrete purchase orders, keeping pharmacy shelves full and momentum intact as Congo strides toward 2026.

You may also like